AGGRASTAT 5 mg/100mL

AGGRASTAT (tirofiban) is an intravenous solution used to prevent blood clots. This medication is often utilized in cardiac procedures to maintain blood flow. AGGRASTAT 5 mg/100mL is designed for controlled administration.

AGGRASTAT is primarily used to prevent blood clots in patients undergoing certain cardiac procedures. It works by inhibiting platelet aggregation, which helps maintain blood flow. This medication is often administered during percutaneous coronary interventions (PCIs) to reduce the risk of ischemic complications. AGGRASTAT 5 mg/100mL is formulated for intravenous use, providing precise dosing for medical professionals.

AGGRASTAT may cause common effects such as bleeding, nausea, and headache. Some patients might experience dizziness or low blood pressure. These effects are generally mild and temporary, but severe reactions should be reported to a healthcare provider immediately.

AGGRASTAT should be handled with care, as it is intended for use in controlled medical settings. Patients with a history of bleeding disorders or recent surgery should use this medication under close supervision. Proper storage and administration techniques are essential to ensure safety and efficacy.

AGGRASTAT may interact with other medications that affect blood clotting, such as anticoagulants and antiplatelet drugs. Alcohol and certain supplements can also influence its effects. It is important to consult a healthcare provider before combining AGGRASTAT with other treatments.